Abstract
Objective
The objective of this study was to evaluate feasibility, safety, perception, and costs of home care for the administration of intensive chemotherapies.
Methods
Patients receiving sequential chemotherapy in an inpatient setting, living within 30 km of the hospital, and having a relative to care for them were offered home care treatment. Chemotherapy was administered by a portable, programmable pump via an implantable catheter. The main endpoints were safety, patient’s quality of life [Functional Living Index—Cancer (FLIC)], satisfaction of patients and relatives, and costs.
Results
Two hundred days of home care were analysed, representing a total of 46 treatment cycles of intensive chemotherapy in 17 patients. Two cycles were complicated by technical problems that required hospitalisation for a total of 5 days. Three major medical complications (heart failure, angina pectoris, and major allergic reaction) could be managed at home. Grades 1 and 2 nausea and vomiting occurring in 36% of patients could be treated at home. FLIC scores remained constant throughout the study. All patients rated home care as very satisfactory or satisfactory. Patient benefits of home care included increased comfort and freedom. Relatives acknowledged better tolerance and less asthenia of the patient. Home care resulted in a 53% cost benefit compared to hospital treatment (€420 ± 120/day vs. €896 ± 165/day).
Conclusion
Administration of intensive chemotherapy regimens at home was feasible and safe. Quality of life was not affected; satisfaction of patients and relatives was very high. A psychosocial benefit was observed for patients and relatives. Furthermore, a cost–benefit of home care compared to hospital treatment was demonstrated.
Similar content being viewed by others
References
Caplan GA et al (1999) Hospital in the home: a randomised controlled trial. Med J Aust 170(4):156–160
Richards SH et al (1998) Randomised controlled trial comparing effectiveness and acceptability of an early discharge, hospital at home scheme with acute hospital care. BMJ 316(7147):1796–1801 [erratum appears in BMJ 1998 Sep;317(7161):786]
Santos-Eggimann B et al (2001) Heart failure and community-acquired pneumonia: cases for home hospital? Int J Qual Health Care 13(4):301–307
Shepperd S et al (2008) Admission avoidance hospital at home. Cochrane Database Syst Rev 4:CD007491
Shepperd S et al (1998) Randomised controlled trial comparing hospital at home care with inpatient hospital care. II: cost minimisation analysis. BMJ 316(7147):1791–1796
Wilson A et al (1999) Randomised controlled trial of effectiveness of Leicester hospital at home scheme compared with hospital care. BMJ 319(7224):1542–1546 [see comment]
Fernandez-Aviles F et al (2006) Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. J Clin Oncol 24(30):4855–4861
Meisenberg BR et al (1997) Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. J Clin Oncol 15(1):11–17
Svahn BM et al (2008) Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation 85(7):1000–1007
Westermann AM et al (1999) At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. Ann Oncol 10(5):511–517
Hooker L, Kohler J (1999) Safety, efficacy, and acceptability of home intravenous therapy administered by parents of pediatric oncology patients. Med Pediatr Oncol 32(6):421–426
Jayabose S et al (1992) Home chemotherapy for children with cancer. Cancer 69(2):574–579
Stevens B et al (2006) Children receiving chemotherapy at home: perceptions of children and parents. J Pediatr Oncol Nurs 23(5):276–285
King MT et al (2000) Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy. Int J Health Serv 30(3):557–579
Vinciguerra V et al (1986) A comparative assessment of home versus hospital comprehensive treatment for advanced cancer patients. J Clin Oncol 4(10):1521–1528
Hirtzlin I, Préaubert-Hayes N (2005) In-hospital and at-home cancer chemotherapy: a comparison of costs and organisation of care. H.E.a.P.H.D., Haute Autorité de Santé, Paris, pp 1–9
Remonnay R et al (2002) Economic evaluation of antineoplasic chemotherapy administered at home or in hospitals. Int J Technol Assess Health Care 18(3):508–519
Kelly D et al (2004) Achieving change in the NHS: a study to explore the feasibility of a home-based cancer chemotherapy service. Int J Nurs Stud 41(2):215–224
Miller AB et al (1981) Reporting results of cancer treatment. Cancer 47(1):207–214
Schipper H et al (1984) Measuring the quality of life of cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 2(5):472–483
Dubois A, Santos-Eggimann B (2001) Evaluation of patients’ satisfaction with hospital-at-home care. Eval Health Prof 24(1):84–98
Montalto M (1996) Patients’ and carers’ satisfaction with hospital-in-the-home care. Int J Qual Health Care 8(3):243–251
Close P et al (1995) A prospective, controlled evaluation of home chemotherapy for children with cancer. Pediatrics 95(6):896–900
Stevens B et al (2006) Economics of home vs. hospital breastfeeding support for newborns. J Adv Nurs 53(2):233–243
van Tiel FH et al (2005) Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia. Ann Oncol 16(2):195–205
Acknowledgements
This study was partially funded by a grant from the University Hospital
Conflict of interest statement
The authors have no financial or personal relation with other people or organisations that could have inappropriately influenced the planning, conduct or analysis of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lüthi, F., Fucina, N., Divorne, N. et al. Home care—a safe and attractive alternative to inpatient administration of intensive chemotherapies. Support Care Cancer 20, 575–581 (2012). https://doi.org/10.1007/s00520-011-1125-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-011-1125-9